mRNA-4157/V940 is an investigational personalized #cancer#vaccine consisting of a single #mRNA coding for up to 34 neoantigens that is designed to stimulate an immune response by generating specific T cell responses based on the unique mutational signature of a patient’s #tumor.
New🔥 #DataScience#Bioinformatics resource: 850,000‼️ #scRNAseq cells from 226 samples across 10 cancer types draw a map of the tumor microenvironment, in particular fibroblasts.
Let’s see👇what are the main contributions of this work & what this means for #cancer#Genomics🧵
It’s spatial profiling day on @biorxivpreprint!
Now @10xGenomics out with a preprint on integrated single cell, spatial and in situ analysis of FFPE tissue. Very excited by the extension of these high dimensional technologies to archival samples!
https://t.co/2ekTRvIoAG
Presenting Slide-TCR-seq: our method for measuring the transcriptomes of cells & T cell receptor (TCR) sequences in situ!
This collaboration w/ Bryan Iorgulescu, Shuqiang Li, Catherine Wu, and @insitubiology led to some cool findings...
https://t.co/bamg5yCToX
1/8
Cancer #immunotherapy#DataScience resource of the week: #scRNAseq & #scTCRseq atlas of 400,000‼️T cells from 316 patients of 21 cancer types, derived from tumors, adjacent normal tissue, and peripheral blood.Half of data newly sequenced, half gathered from literature. 🧵(1/4)
The most recent paper from the lab has been published at @jitcancer. We employed single-cell mass cytometry to delineate tumor-associated and systemic immune profiles in #PancreaticCancer.
https://t.co/LAQKoVan1H
“This grant proposal describes breeding experiments in peas. This reviewer remains unconvinced about the translational benefits. Applicant should switch to a more economically important crop like wheat. Applicant’s productivity also an issue, no paper published in last 8 years”.
Here's a neat tech, where they capture T cells based on adherence to target tumour cells in a microfluidic device:
https://t.co/ToQATe275V
A fast assay that addresses a lot of problems from say sticky multimers, and twiddling the pressure lets you sort out high avidity binders.
Minimize the chances of missing a T cell population critical to your therapy success!💪🏼
OS-T enables #TCR#sequencing of up to #1M#cells per sample at cellular resolution.
Submit your #abstract and opt-in to an opportunity to be awarded 4 free samples!
https://t.co/rzvpEoHKjb
So lucky to have been able to work with @efaithd an incredibly talented, creative and overall amazing scientist! I have no doubt you will continue to do incredible work. Congratulations!
Our immune system follows circadian rhythm. A new review @SciImmunology. And why getting Covid vaccines in the morning elicits a better antibody and cellular immune response
https://t.co/nqDxy3XYv1 @ScheiermannLab
I earned my PhD yesterday! In person too! What a surreal feeling all around. Wildly thankful for my incredible mentors on this journey, @FertigLab @NeehaZaidi@DrLizJaffee and everyone who made this possible.
It's a @NEJM case report, but a groundbreaking one. For a woman with refractory pancreatic cancer, genetically engineered T cells directed towards the KRAS driver mutation achieved substantial tumor regression
https://t.co/X7NuoRehtq
Our new review ‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses” is out @NatImmunol. Great team effort with Dietmar Zehn @LabOxenius Robert Thimme @teximmed2 and Gustavo Almeida https://t.co/ZVOeYfMFoe